PharmaBoardroom

Top 15 Pharma Companies in Turkey Ranking

The top 15 pharma companies in Turkey ranked by sales for 2017. Homegrown champion Ibrahim leads the way with USD 420 million worth of sales and a 5.8…

Interview: James Burt – Executive Vice President Europe and…

Heading Accord Healthcare’s European, Middle East and North African operations, James Burt highlights the rapid growth the company has achieved…

Malta Pharma Exports and Trade Snapshot

Malta has the second largest pharma trade balance per capita in the EU, the tenth in total, and was the continent's fastest growing pharma exporter…

Africa: The Launchpad for Indian Pharma

Although most industry observers expect that Indian pharma exports to the US will pick up again in the coming years, Indian companies have – in the…

Interview: João Madeira – General Manager, Mylan Portugal

Experienced country manager, João Madeira, introduces Mylan’s new vision to be a global healthcare company serving patients across the world with…

The Trump Bounce for Pharma M&A

Blue-chip drug makers holding USD 200 billion in cash, mostly overseas, will start investing more of it in mergers and acquisitions (M&A) after…

Digital Assets: The Next “Must-Have” Acquisition for Big…

Digital health startups raised over USD six billion in equity financing in 2016, representing a five-year compound annual growth rate of 32 percent…

A Critical Juncture for the UK’s Vaccines Industry

Britain, home of the discovery of the world’s first ever vaccine, has long been championing a pharma sub-segment forecast to reach a global market…

Interview: Thomas Bo Bjorn Klee – Managing Director,…

Thomas Bo Bjorn Klee, managing director of Lundbeck UK and Ireland, describes the global restructuring program Lundbeck initiated two years ago to…

Erik Nordkamp – Managing Director, Pfizer UK

Erik Nordkamp, managing director of Pfizer UK shares his thoughts on the future of healthcare and the role that Pfizer and the UK can play in shaping…

Interview: Silvia Guichardo – General Manager, GSK Portugal

Hailing from the Dominican Republic, Silvia Guichardo brings a fresh perspective as well as both US and Iberian experience to GSK Portugal. Six months…

Interview: Lucas Sigman – Director General, Chemo, Spain

Lucas Sigman, director general of Chemo, a leader in the research, development and manufacture of finished dosage forms and the active pharmaceutical…

Tagged with ARM